Director · Indivior Pharmaceuticals, Inc. · Common Stock
Side
A
Value
—
Shares
6,518
Price
—
Executed
May 13, 2026
Disclosed
May 14, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
May 13 executedMay 14, 2026 disclosed
INDV · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 68.4% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Humphreys Keith filed this Form 4 reporting a grant or award of INDV on May 13, 2026. It became public on May 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Humphreys Keithcik:0002014900
Issuer
Indivior Pharmaceuticals, Inc.cik:0001625297
Revision history · 0
No field has changed since this record was first ingested.
